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the patch. Patients were examined using trans-thoracic
echocardiography consecutively at discharge form the
hospital, and at 3–6 months and yearly after discharge.
The mean follow up time was 78 months. The early mor-
tality was 5.19% (17 patients), and there were no late mor-
tality. The highest mortality was reported during the
beginning of the pediatric surgical program. The mortal-
ity for the last 100 patients was 1%. The pressure gradient
across the pulmonary valve in 249 patients (87%, was less
than 20 mmHg. Mild pulmonary stenosis (pressure gradi-
ent of 20–40 mmHg) was present in 32 patients (11.14%)
and moderate pulmonary stenosis with gradient
40–60 mmHg was manifested in 4 patients (1.39%).
Reconstruction of the new Pulmonary artery during the
ASO, using the quadrangular autologous fresh pericar-
dial patch, is effective and reproducible in reducing the
incidence of post-operative pulmonary stenosis.
http://dx.doi:10.1016/j.jsha.2016.04.008
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Valvular heart disease is a major and serious health-
care issue. There is an increasing evidence that Nurse-
led anticoagulation clinics may improve patients’ man-
agement and care.This is a retrospective comparison
study that included the first 94 patients enrolled in the
Nurse Led Prosthetic Valve Anticoagulation Clinic
(PVATC) in King Abdul-Aziz Cardiac Centre between
April and June 2013, and received Warfarin by General
Cardiology Clinics for one year pre enrollment in
PVATC, and one year after. Time in Therapeutic Range
(TTR) of the International Normalized Ratio (INR) was
calculated and compared between pre and post PVATC
enrolment. Other data including demographics and
comorbidities were collected and analyzed. Mean age of
patients was 53  12.5 years and males were 56%. Atrial
fibrillation was found in 37%, Diabetes Mellitus in 28%
and Hypertension in 34%. Mean TTR was 72% pre enroll-
ment in PVATC as compared to 78.9% after (P < 0.006).
Median TTR was 75% pre, and 81.5% after attending
the PVATC (P < 0.0001). 56% of patients pre enrollment
had TTR values above 70% threshold, compared to 75%
after enrollment. Nurse-Led PVATC has significant
impact on the care provided to patients receiving anticoa-
gulation treatment.
http://dx.doi:10.1016/j.jsha.2016.04.009
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Despite advanced sterile techniques in cardiac device
implantations, long-term complications such as wound
infections and/or lead-induced endocarditis can develop
mandating lead and device extraction. It has been sug-
gested that lead extraction carries a risk of new-onset
Tricuspid Regurgitation (TR), or a deterioration of a for-
merly known regurgitant valve. Yet, there is no enough
scientific evidence to our knowledge to back this claim.
In this study we aim to explore the risk of TR following
lead extraction.We conducted a retrospective chart
review in 113 patients whom underwent lead extraction
at Prince Sultan Cardiac Center in Saudi Arabia during
the period of Jan, 2002 to Jul, 2015. Six patients under-
went lead extraction twice, making the total number of
extractions to be 119. Of this study cohort, we include
52 cases who had Tricuspid valve function evaluation
via Transthoracic Echocardiography (TTE) prior to and
after device and lead extraction. TR severity was
assessed using a grading system as the following; nor-
mal, mild, mild-to-moderate, moderate-to-severe, and
severe. Worsening or improvement by more than 1
grade was considered clinically significant. TR following
lead extraction was examined over a median of 5
months. Of the 52 cases included in this study, 37
(71.2%) were males and 15 (28.8%) were females, with
a mean age of 46 (SD = 18) years. Eleven patients
(21.2%) experienced worsening of TR (3 had normal
functioning valves before extraction, and 8 were known
to have TR prior to extraction), 2 (3.8%) had improve-
ment, and the majority (75.0%) did not experience any
significant changes. Compared with those who had no
change, average lead duration was higher in the wor-
sening TR group (67.2 vs. 27.9 months). A lead-
attached vegetation was detected in 4 out of the 11
patients with TR. Lead type (High-voltage vs. Pacing)
was not predictive of TR, 5 (45.5%) of the patients in
the worsening group had high-voltage leads, while the
remaining (54.5%) had pacing leads across the valve.
Our study being a simple descriptive study could not
find overwhelming evidence to support the claim that
there is an elevated risk of new onset TR or deteriora-
tion of a regurgitant valve following pacemaker/defibril-
lator lead extraction. However, our study being a simple
observational study with a considerably small sample
size may influence the findings. Lack of appropriate
control group in this study is a limitation in appraising
the hypothesis. As there is scarcity of data in this impor-
tant area of cardiac research, our findings should
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